c-Myc, a potent oncogene, is a key player in regulating cell growth and proliferation. Inhibitors of c-Myc are being explored as potential anti-cancer drugs. By targeting c-Myc, they aim to curtail the uncontrolled cell division seen in various cancers. Research into these inhibitors holds promise for developing novel, effective cancer treatments.
